[PDF] Top 20 Implementación de un sistema de costos para la Empresa Textil SPRINT de la ciudad de Riobamba

... eosinophilic asthma that is uncontrolled with ICS and an additional asthma agent ...Eosinophilic asthma was defined in mepolizumab trials as a blood eosinophil count of ≥ 150 cells/μL at initiation ... See full document

... Because biologics involve biological materials, their protection often have to rely on process patents, rather than product ...to biologics because those products are not considered “new chemical entities” ... See full document

... exacerbations also predict better outcome measured by exacerbations [9, 11] though this may be due to regression to the mean. Other baseline characteristics when used as predictors show more variable results. In one ... See full document

... using biomarkers and treatable traits to develop and select disease-modifying strategies that are tailored to individual patients has great ...targeted biomarkers, treatable traits and phenotypes may be a ... See full document

... Sputum biomarkers were further analyzed by the area under the curve (AUC) statistics for their predictive capability to distinguish ACOS from asthma, and ACOS and asthma from COPD or ...with ... See full document

... nonallergic asthma, also experiencing recurrent disease exacerbations despite the use of inhaled corticoster- oids at relatively high ...important biomarkers of eosinophilic airway inflammation are sputum ... See full document

... Severe asthma or therapy-resistant asthma in children is a heterogeneous disease that affects all ...appropriate biomarkers, it will assist in providing the patient with more personalized and ... See full document

... predict asthma control status in childhood ...ferent asthma phenotypes with regard to disease control, severity, allergy, comorbidity, obesity, age and smoking ...and asthma severity but it ... See full document

... of asthma are readily controlled, but it is an important cause of school absenteeism, restricted activity and anxiety for the child and ...with asthma after several attacks instead that should be diagnosed ... See full document

... Abstract: Biologics are novel and important agents in the treatment of severe ...four biologics currently licensed and used in the treatment of psoriasis in the European ...of biologics in psoriasis ... See full document

... the age of three, or in immunocompromised patients, there should be no major difference between latent infection and illness, as the infection often advances at a very fast pace ... See full document

... Thirty wet AMD patients and 30 healthy volunteers were enrolled in this study. The groups were matched for age, sex, and detailed medical history (hypertension, diabetes, coronary heart disease, cerebrovascular ... See full document

... of asthma including both variable respiratory symptoms and variable expiratory airflow limitation were identified and defined as having ...inflammatory biomarkers such as frac- tional exhaled nitric oxide ... See full document

... elderly asthma patients are ...aging, asthma, coexisting diseases, and various medications in elderly ...and asthma management plans for elderly patients should take into account all the fol- lowing ... See full document

... termed biologics or ...of biologics are designed and destined for the parenteral route of ...of biologics both for parenteral and noninvasive ... See full document

... Prostate cancer (PCa) is the major cause of the death of men population globally. multiple factors are involved in the initiation and progression of PCa. This study aimed to evaluate different metabolic pa- rameters in ... See full document

... Before recruitment, in- and exclusion criteria for eli- gible individuals are assessed by participating centres. In the case of children, this is additionally performed with screening leaflets used by participating ... See full document

... obstruction. Asthma can be classified as “atopic” or “nonatopic” based on the presence (atopic) or absence (nonatopic) of specific immunoglobulin (Ig)E antibodies to common environmental ...Atopic asthma is ... See full document

... similar biologics are not new drug products and their risk will be similar to reference biologic; however as similar biologics are authorized based on a reduced preclinical and clinical data package, it is ... See full document

... including biologics have changed the therapeutic management of psoriasis, providing physicians with the opportunity to directly target the known key media- tors in the pathogenesis of this ... See full document